Immunomedics, Inc.
(NASDAQ : IMMU)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading IMMU News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.01%70.491.0%$914.02m
AMGNAmgen Inc.
1.53%179.230.8%$649.06m
BIIBBiogen Inc.
1.62%293.270.9%$502.49m
CELGCelgene Corporation
0.62%124.271.0%$501.11m
INCYIncyte Corporation
1.58%135.202.3%$451.54m
REGNRegeneron Pharmaceuticals, Inc.
1.43%378.851.9%$338.90m
ALXNAlexion Pharmaceuticals, Inc.
1.51%133.232.0%$303.80m
TSROTESARO, Inc.
-3.99%180.8515.3%$161.30m
ILMNIllumina, Inc.
1.23%169.453.9%$158.91m
EXELExelixis, Inc.
3.99%22.395.5%$140.89m
VRTXVertex Pharmaceuticals Incorporated
0.42%91.002.6%$140.36m
CLVSClovis Oncology, Inc.
2.94%59.5116.4%$119.33m
BMRNBioMarin Pharmaceutical Inc.
0.39%94.303.9%$109.15m
AAgilent Technologies, Inc.
1.25%51.941.7%$107.79m
ACADACADIA Pharmaceuticals Inc.
-3.42%36.8119.0%$93.80m

Company Profile

Immunomedics, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. The company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. It markets and sells its products in the U.S. and throughout Europe. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.